DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Hilton Washington DC/Rockville Hotel & Executive Meeting Ctr.

2017 年 04 月 24 日 7:30 上午 - 2017 年 04 月 26 日 12:00 下午

1750 Rockville Pike, , Rockville, MD 20852 , USA

CMC Workshop

Session 6: ICH Q12 Life Cycle Management: Benefits and Challenges

Session Chair(s)

Jean-Louis  Robert, PHD

Jean-Louis Robert, PHD

Former CHMP/CVMP QWP Chair

Luxembourg

Moheb M. Nasr, PHD, MS

Moheb M. Nasr, PHD, MS

Principal

Nasr Pharma Regulatory Consulting, United States

While the concepts in ICH Q8, Q9, Q10, and Q11 provided opportunities for a more science- and risk-based approach for assessing changes across the life cycle, several gaps exist which limit full realization of expected regulatory flexibility. These gaps include harmonized change management best practices that effectively evaluates the impact of change on quality, clarity of the regulatory commitments (established conditions) in regulatory files and distinguishing them from supporting information, and the development and submission of product specific life cycle management strategy document in regulatory files. ICH Q12 industry and regulatory experts will share their perspectives on ICH Q12 and provide an update on progress made to date. Presentations will be followed by panel discussions.

Speaker(s)

Moheb M. Nasr, PHD, MS

An Industry Perspective

Moheb M. Nasr, PHD, MS

Nasr Pharma Regulatory Consulting, United States

Principal

Jean-Louis  Robert, PHD

EU Regulatory Perspective

Jean-Louis Robert, PHD

Luxembourg

Former CHMP/CVMP QWP Chair

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。